Literature DB >> 6203283

Lichen planus and chronic active hepatitis. A retrospective survey.

A Rebora, F Rongioletti.   

Abstract

In a retrospective survey 95 in-patients with non erosive lichen planus (LP) were summoned to be investigated by means of routine liver tests. 44 patients responded. Remarkable abnormalities of liver tests were found in 6 patients who were further studied for antibodies to smooth muscle and mitochondria and submitted to liver biopsy. Histological diagnosis revealed chronic active hepatitis (CAH) in 5 cases (11.3%). Such an impressive prevalence and the histologic and immunologic similarities between the two diseases support the view that the association LP-CAH is not fortuitous and that both diseases may have the same autoimmune pathogenesis. Accordingly LP may be regarded as a major risk factor for liver cirrhosis.

Entities:  

Mesh:

Year:  1984        PMID: 6203283

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

Review 1.  Nonhepatic manifestations and combined diseases in HCV infection.

Authors:  S J Hadziyannis
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

2.  Lichen planus and liver diseases: a multicentre case-control study. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED).

Authors: 
Journal:  BMJ       Date:  1990-01-27

3.  Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection.

Authors:  Y Da Nagao; M Sata; H Suzuki; K Tanikawa; K Itoh; T Kameyama
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

4.  The triad of lichen planus, thymoma and liver cirrhosis-hepatoma. First reported case.

Authors:  J A Hassan; S Saadiah; A M Roslina; M Atan; N Masir; S Hussein; T Ganesapillai
Journal:  Malays J Med Sci       Date:  2000-07

5.  Long-term impact of certain coexisting extrahepatic unisystem and multisystem manifestations on trends in incidence of liver cirrhosis in treatment-naïve patients with chronic hepatitis C: A nested case-control study.

Authors:  Chun-Hsiang Wang; Shih-Fang Ou; Yuan-Tsung Tseng
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.